Issuer Credit Research

Issuer Flash: Shin Kong Life Insurance

Issuer Flash: Shin Kong Life Insurance

Report date: 2026-06-05 Event date: 2026-06-03 Event title: 1Q26 Results

1. Flash Conclusion

Shin Kong Life Insurance’s 1Q26 results are a positive data point against the capital, spread, and FX hedging concerns that remained at legacy Shin Kong Life at end-2025. The post-merger company reported NT$11.9bn of net profit after tax, while new business CSM, first-year premiums, the foreign-currency policy mix, hedging costs, and liability costs all moved in a direction that mitigates the weaknesses seen in 2025.

However, the conclusion of this Flash is that this is “a first step in confirming improvement,” not “confirmation that the capital issue has been resolved.” The reported figures are for the period after the life insurance company integration on January 1, 2026 and after the transition to IFRS 17. They cannot be mechanically compared with legacy Shin Kong Life’s standalone end-2025 capital adequacy shortfall to conclude that capital headroom has recovered sufficiently. While the improvement in positive spread, CSM, and foreign-currency policies is credit-positive, TIS, the net worth ratio, stress sensitivity, ratings, and the practical succession of the USD Tier 2 instruments remain the next items to verify.

2. Newly Disclosed Information

In its first-quarter analyst presentation dated June 3, 2026, TS Holdings presented 1Q26 figures on an IFRS 17 basis. The presentation of the numbers differs from the IFRS 4-basis figures for 2023-2025.

In the life insurance business, Shin Kong Life reported 1Q net profit after tax of NT$11.9bn. The company explained that earnings were supported by stable CSM amortisation and recurring investment income. First-year premiums were NT$37.7bn, up 78% year on year, and the foreign-currency policy ratio was 73.3%. New business CSM was NT$17.7bn, while the CSM balance increased from NT$260.7bn on January 1 to NT$280.3bn at end-March.

On the investment side, total investments were NT$3,100.9bn in 1Q26, while overseas fixed-income assets accounted for 60.8% of investments, or NT$1,885.8bn. The recurring yield before hedging was 4.13%, and the liability cost was 2.2%, with the company showing an investment yield above its liability cost. Hedging costs were 1.25%, down from 2.17% in 2025. However, the 2025 hedging cost was a legacy Shin Kong Life figure and does not reflect the post-merger scope after the merger with Taishin Life. The foreign exchange valuation reserve was NT$104.1bn at end-March, up slightly from NT$103.5bn on January 1. This is more a data point for checking the buffer against Taiwan dollar appreciation and hedging burden than evidence of a major improvement.

3. Credit Interpretation

The most important change is that the 2025 structure, in which the liability cost exceeded the investment yield, appears to have reversed based on the disclosed 1Q26 metrics. The combination of a 4.13% recurring yield before hedging, a 2.2% liability cost, and a 1.25% hedging cost indicates some relief on both spread and FX burden.

Even so, this does not yet prove structural improvement. The first quarter is an early post-merger period, and the scope of assets, accounting treatment, equity classification, and insurance liability valuation are not continuous with the standalone time series of legacy Shin Kong Life. The 73.3% foreign-currency policy ratio could improve matching with foreign-currency assets, but policyholder FX risk, sales quality, credit and interest-rate risk in foreign-currency assets, and liquidity upon surrender remain relevant.

The increase in CSM is also positive, but for bondholders it is not directly usable capital or liquidity. New business CSM of NT$17.7bn and end-March CSM of NT$280.3bn strengthen the base for future earnings, but they are affected by claims, surrenders, the profitability of protection-type products, reinsurance, and discount-rate movements. The reported earnings and CSM should be separated from completion of capital restructuring.

From a rating perspective, the Quick Fact shows Shin Kong Life at Fitch BBB- on Rating Watch Evolving and S&P BBB+ with a Negative outlook. Whether the first-quarter improvement will lead to the resolution of the rating watch or stabilisation of the outlook remains unconfirmed, and uncertainty around capital, FX sensitivity, and the IFRS 17/TIS transition remains.

4. Key Figures

Item 1Q26 disclosed figure Credit interpretation
Shin Kong Life net profit after tax NT$11.9bn Confirms earnings generation in the early post-merger period
First-year premiums NT$37.7bn Up 78% year on year. Product mix and sales quality require verification
Foreign-currency policy ratio 73.3% Could contribute to better matching with foreign-currency assets, but sales quality and policyholder risk remain
New business CSM NT$17.7bn Accumulation of future earnings. Should be distinguished from immediate capital headroom
CSM balance NT$280.3bn Increased from NT$260.7bn on January 1
Overseas fixed-income assets NT$1,885.8bn / 60.8% of investments Still heavily dependent on overseas rates, credit, and FX
Recurring yield before hedging / liability cost 4.13% / 2.2% Positive spread based on disclosure. Scope and accounting transition should be noted
Hedging cost 1.25% Down from 2.17% in 2025. Sustainability to be confirmed
Foreign exchange valuation reserve NT$104.1bn Slightly up from NT$103.5bn on January 1. A data point for checking the buffer against FX and hedging burden

5. Items to Monitor Next

From the next reporting period onward, the key issue is whether the spread improvement and CSM accumulation seen in 1Q26 translate into improvements in capital and ratings. Specifically, it will be necessary to check TIS as of end-March, the net worth ratio, stress sensitivity, the foreign exchange valuation reserve, the sustainability of hedging costs, and the profitability of claims, surrenders, and protection-type products.

For the USD Tier 2 instruments, the practical succession or substitution of the guarantor after the merger, subordination, redemption and interest payment restrictions, and regulatory capital recognition remain items to monitor. The results are a positive credit development for the issuer, but Tier 2 investors still face issues around security ranking and regulatory approval. At this stage, the appropriate view is: “positive progress confirmed, but still in the phase of assessing capital headroom and the direction of ratings.”

6. Sources